Newborn screening describes various tests that can occur during the first few hours or days
of a newborn's life and have the potential for preventing severe health problems, including …

Background Previous global analyses, with known underdiagnosis and single cause per
death attribution systems, provide only a small insight into the suspected high population …

Government activities around NBS are increasing in India and there is increased emphasis
on pilot programs for sickle cell NBS in sub-Saharan Africa. Genetic counseling training in …

Rare diseases (RDs) cause considerable death and disability in Latin America. Still, there is
no consensus on their definition across the region. Patients with RDs face a diagnostic …

Background Sickle cell disease is highly prevalent in sub-Saharan Africa, where it accounts
for substantial morbidity and mortality. Newborn screening is paramount for early diagnosis …

In an effort to explore new knowledge and to develop meaningful collaborations for
improving child health, the First Pan African Workshop on Newborn Screening was …

Sickle cell disease (SCD) is a worldwide genetic blood disorder. Roughly 400,000 babies
are born with SCD each year worldwide. More than 75% of these births occur in sub …

Newborn screening (NBS) is an important part of public healthcare systems in many
countries. The provision of information to parents about NBS is now recognised as an …

Significant part of Southeastern Europe (with a population of 76 million) has newborn
screening (NBS) programs non-harmonized with developed European countries. Initial …

Background Individual inborn errors of metabolism (IEMs) are rare disorders. Expanded
newborn screening for IEMs by tandem mass spectrometry (TMS) is an efficient approach for …